Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
15,450
0.00 (0.00%)
At close: Jan 23, 2026
Sam-A Pharm. Revenue
Sam-A Pharm. had revenue of 15.11B KRW in the quarter ending September 30, 2025, a decrease of -27.94%. This brings the company's revenue in the last twelve months to 76.66B, down -24.39% year-over-year. In the year 2024, Sam-A Pharm. had annual revenue of 95.58B, down -1.68%.
Revenue (ttm)
76.66B
Revenue Growth
-24.39%
P/S Ratio
1.23
Revenue / Employee
251.34M
Employees
305
Market Cap
94.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 95.58B | -1.63B | -1.68% |
| Dec 31, 2023 | 97.21B | 15.51B | 18.99% |
| Dec 31, 2022 | 81.70B | 27.03B | 49.45% |
| Dec 31, 2021 | 54.67B | 1.01B | 1.89% |
| Dec 31, 2020 | 53.65B | -17.91B | -25.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 300.96B |
| H.PIO | 257.56B |
| Daehan Nupharm | 201.59B |
| HYUNDAI BIOLAND | 129.68B |
| Sinsin Pharmaceutical | 110.29B |
| Hwail Pharmaceutical | 107.87B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 102.11B |
| High Tech Pharm | 75.60B |